Ameriprise’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-53,647
| Closed | -$564K | – | 3906 |
|
|
2023
Q4 | $564K | Sell |
53,647
-9,757
| -15% | -$103K | ﹤0.01% | 3411 |
|
|
2023
Q3 | $560K | Sell |
63,404
-4,788
| -7% | -$42.3K | ﹤0.01% | 3364 |
|
|
2023
Q2 | $658K | Buy |
68,192
+2,584
| +4% | +$24.9K | ﹤0.01% | 3337 |
|
|
2023
Q1 | $905K | Sell |
65,608
-42
| -0.1% | -$579 | ﹤0.01% | 3200 |
|
|
2022
Q4 | $997K | Buy |
65,650
+3,949
| +6% | +$60K | ﹤0.01% | 3128 |
|
|
2022
Q3 | $561K | Buy |
61,701
+19,520
| +46% | +$177K | ﹤0.01% | 3345 |
|
|
2022
Q2 | $359K | Sell |
42,181
-526
| -1% | -$4.48K | ﹤0.01% | 3508 |
|
|
2022
Q1 | $837K | Buy |
42,707
+13,839
| +48% | +$271K | ﹤0.01% | 3283 |
|
|
2021
Q4 | $701K | Buy |
28,868
+22,569
| +358% | +$548K | ﹤0.01% | 3401 |
|
|
2021
Q3 | $246K | Buy |
+6,299
| New | +$246K | ﹤0.01% | 3650 |
|